Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah C Rutherford

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Clinical Advances in Hematology & Oncology : H&O|August 23, 2019
Surveillance scanning in lymphomaSarah C Rutherford
Hematology. American Society of Hematology. Education Program|December 5, 2025
Molecular subtypes of DLBCL: are we ready to translate our knowledge into the change of treatment paradigms?Sarah C Rutherford
Leukemia & Lymphoma|May 21, 2019
PET beyond Deauville in diffuse large B-cell lymphomaSarah C Rutherford
Hematology/Oncology Clinics of North America|February 18, 2026
Classic Hodgkin Lymphoma in the Older Adult: What's New?Carrie Sha, Sarah C Rutherford
JAMA Oncology|July 14, 2018
Management of Relapsed and Refractory Hodgkin Lymphoma in 2018Sarah C Rutherford, John P Leonard
Oncology (Williston Park, N.Y.)|May 19, 2017
The Uncertainties of Rituximab and Related Therapies, 20 Years After ApprovalSarah C Rutherford, John P Leonard
Blood|October 21, 2017
Lymphoma "benchmark" or "bench-smudge"?Sarah C Rutherford, John P Leonard
Oncology (Williston Park, N.Y.)|September 25, 2018
DLBCL Cell of Origin: What Role Should It Play in Care Today?Sarah C Rutherford, John P Leonard
British Journal of Haematology|January 30, 2018
Bone marrow biopsies not indicated for response assessment in follicular lymphoma trials regardless of type of imaging study - Response to Adams and KweeSarah C Rutherford, John P Leonard
Blood|February 28, 2025
The Future of Follicular Lymphoma Management: Strategies on the HorizonErin Mulvey, Sarah C Rutherford, John P Leonard
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Clinical Advances in Hematology & Oncology : H&O|August 23, 2019
Surveillance scanning in lymphomaSarah C Rutherford
Hematology. American Society of Hematology. Education Program|December 5, 2025
Molecular subtypes of DLBCL: are we ready to translate our knowledge into the change of treatment paradigms?Sarah C Rutherford
Leukemia & Lymphoma|May 21, 2019
PET beyond Deauville in diffuse large B-cell lymphomaSarah C Rutherford
Hematology/Oncology Clinics of North America|February 18, 2026
Classic Hodgkin Lymphoma in the Older Adult: What's New?Carrie Sha, Sarah C Rutherford
JAMA Oncology|July 14, 2018
Management of Relapsed and Refractory Hodgkin Lymphoma in 2018Sarah C Rutherford, John P Leonard
Oncology (Williston Park, N.Y.)|May 19, 2017
The Uncertainties of Rituximab and Related Therapies, 20 Years After ApprovalSarah C Rutherford, John P Leonard
Blood|October 21, 2017
Lymphoma "benchmark" or "bench-smudge"?Sarah C Rutherford, John P Leonard
Oncology (Williston Park, N.Y.)|September 25, 2018
DLBCL Cell of Origin: What Role Should It Play in Care Today?Sarah C Rutherford, John P Leonard
British Journal of Haematology|January 30, 2018
Bone marrow biopsies not indicated for response assessment in follicular lymphoma trials regardless of type of imaging study - Response to Adams and KweeSarah C Rutherford, John P Leonard
Blood|February 28, 2025
The Future of Follicular Lymphoma Management: Strategies on the HorizonErin Mulvey, Sarah C Rutherford, John P Leonard
Pageof 4